The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha
Mohammad Reza Sadeghi(Tabriz University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Hadiseh Kheiry(Tabriz University of Medical Sciences), Vahid Karpisheh(Tabriz University of Medical Sciences), Atefeh Khodakarami(Tabriz University of Medical Sciences), Asieh Zarei(Tabriz University of Medical Sciences), Mortaza Raeisi(Tabriz University of Medical Sciences), Mehdi Yousefi(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Fariba Karoon Kiani(Tabriz University of Medical Sciences), Asma Moslehi(Tabriz University of Medical Sciences), Ali Akbari(Harvard University), Badrossadat Rahnama(Tabriz University of Medical Sciences), Ali Masjedi(Tabriz University of Medical Sciences)
Cited by 20
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202